The Expanding Spectrum of Mutations in Hereditary Angioedema

Area of Science:

• Genetics
• Immunology
• Rare Diseases

Background:

• Hereditary angioedema (HAE) is a rare genetic disorder.
• C1 inhibitor (C1-INH) deficiency, caused by SERPING1 mutations, is the primary known cause of HAE.
• Recent discoveries have identified additional genetic factors contributing to HAE with normal C1-INH levels.

Purpose of the Study:

• To review the evolution of genetic discoveries in HAE.
• To highlight the impact of advanced sequencing technologies on identifying novel HAE-associated genes.
• To discuss the implications of these findings for understanding HAE pathogenesis and developing treatments.

Main Methods:

• Review of genetic studies on hereditary angioedema.
• Analysis of next-generation sequencing (NGS) data for gene discovery.
• Identification of mutations in SERPING1, F12, ANGPT1, PLG, KNG1, MYOF, and HS3ST6.

Main Results:

• C1 inhibitor (C1-INH) deficiency is the established cause of HAE (HAE-C1-INH).
• Mutations in F12 were identified in HAE patients with normal C1-INH.
• Recent advances in genomics identified mutations in ANGPT1, PLG, KNG1, MYOF, and HS3ST6 in HAE patients with normal C1-INH.

Conclusions:

• Genomic studies have significantly expanded the understanding of HAE genetic causes.
• The identification of new genes provides insights into HAE pathogenesis.
• These discoveries pave the way for novel therapeutic targets and personalized medicine approaches for HAE.